Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (39 ops.)
Latest filing published 02 Jun 2026 for CORCEPT THERAPEUTICS INC, €771k.
Filing timeline
BuySaleJoseph K. Belanoff
Insider track record
Disclosed buys
0
Disclosed sells
39
Signal history
Joseph K. Belanoff: trading record in brief
In 2025, Joseph K. Belanoff filed 32 of the 59 filings in the record, after very quiet years (1 to 4 a year between 2018 and 2024, and 8 in 2016). All concern Corcept Therapeutics Inc, where Belanoff is Chief Executive Officer, and were published between November 9, 2016 and June 2, 2026.
The 38 sales total EUR 45,725,923, with a median of EUR 745,838, and no purchase appears. The three largest are dated July 6, 2022 (EUR 7,218,620), December 12, 2018 (EUR 3,645,074) and March 31, 2025 (EUR 3,073,203). The record also counts 10 option exercises, 5 grants and 6 other filings.
A total of 15 filings fall in the last twelve months, 8 of them sales.
There are 33 of Belanoff's market trades within 30 days of a trade by Sean Maduck, 31 by William Guyer, 30 by Joseph Douglas Lyon and 27 by Daniel N. Swisher Jr., always in the same direction. Filings are published a median of 2 days after the trade.
Companies and markets linked to Joseph K. Belanoff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations59 total
12,837 shares@ US$69.740.0071% mcap3.5% of flowCommon StockSEC:0001193125-26-253459:3
300,000 shares0Common StockSEC:0001193125-26-253459:0
150,000 shares0Common StockSEC:0001193125-26-253459:1
150,000 shares0Common StockSEC:0001193125-26-253459:2
40,000 shares@ US$50.09650.016% mcap7.8% of flowCommon StockSEC:0001193125-26-206540:0
26,198 shares@ US$50.07355.1% of flowCommon StockSEC:0001193125-26-129143:0
243,154 shares0Common StockSEC:0001193125-25-335538:2
243,154 shares0Common StockSEC:0001193125-25-335538:3
306,846 shares@ US$83.5919.0% of flowCommon StockSEC:0001193125-25-335538:1
550,000 shares@ US$3.888.2% of flowCommon StockSEC:0001193125-25-335538:0
40,000 shares@ US$79.769912.5% of flowCommon StockSEC:0001193125-25-307204:0
14,355 shares@ US$74.200.8% of flowCommon StockSEC:0001193125-25-267545:1
10,837 shares@ US$75.140.6% of flowCommon StockSEC:0001193125-25-267545:2
3,590 shares@ US$75.980.2% of flowCommon StockSEC:0001193125-25-267545:3
11,218 shares@ US$74.07863.3% of flowCommon StockSEC:0001193125-25-267545:0
31,190 shares@ US$85.162.0% of flowCommon StockSEC:0001193125-25-230467:1
3,194 shares@ US$85.670.2% of flowCommon StockSEC:0001193125-25-230467:2
5,616 shares@ US$84.28951.8% of flowCommon StockSEC:0001193125-25-230467:0
700 shares@ US$71.010.0% of flowCommon StockSEC:0001193125-25-196313:1
39,300 shares@ US$70.517210.8% of flowCommon StockSEC:0001193125-25-196313:0
16,745 shares@ US$67.80634.5% of flowCommon StockSEC:0000950170-25-103323:0
17,809 shares@ US$68.86894.9% of flowCommon StockSEC:0000950170-25-103323:1
5,446 shares@ US$69.64831.5% of flowCommon StockSEC:0000950170-25-103323:2
615 shares@ US$73.68730.2% of flowCommon StockSEC:0000950170-25-097372:0
3,050 shares@ US$79.480.2% of flowCommon StockSEC:0000950170-25-081939:1
25 of 59 declarations
